Nejat Reza, Torshizi Maziar Fayaz, Najafi David J
Department of Anesthesiology and Critical Care Medicine, Laleh Hospital, Tehran 1467684595, Iran.
Department of Chemical Engineering, Imperial College London, London SW7 2AZ, UK.
Vaccines (Basel). 2023 Jan 17;11(2):204. doi: 10.3390/vaccines11020204.
Since the spread of the deadly virus SARS-CoV-2 in late 2019, researchers have restlessly sought to unravel how the virus enters the host cells. Some proteins on each side of the interaction between the virus and the host cells are involved as the major contributors to this process: (1) the nano-machine spike protein on behalf of the virus, (2) angiotensin converting enzyme II, the mono-carboxypeptidase and the key component of renin angiotensin system on behalf of the host cell, (3) some host proteases and proteins exploited by SARS-CoV-2. In this review, the complex process of SARS-CoV-2 entrance into the host cells with the contribution of the involved host proteins as well as the sequential conformational changes in the spike protein tending to increase the probability of complexification of the latter with angiotensin converting enzyme II, the receptor of the virus on the host cells, are discussed. Moreover, the release of the catalytic ectodomain of angiotensin converting enzyme II as its soluble form in the extracellular space and its positive or negative impact on the infectivity of the virus are considered.
自2019年末致命病毒SARS-CoV-2传播以来,研究人员一直在不懈努力,试图弄清楚该病毒是如何进入宿主细胞的。病毒与宿主细胞相互作用的每一方的一些蛋白质都是这一过程的主要促成因素:(1)代表病毒的纳米机器刺突蛋白;(2)代表宿主细胞的血管紧张素转换酶II,单羧肽酶以及肾素血管紧张素系统的关键组成部分;(3)SARS-CoV-2利用的一些宿主蛋白酶和蛋白质。在这篇综述中,将讨论SARS-CoV-2进入宿主细胞的复杂过程,包括相关宿主蛋白的作用,以及刺突蛋白中倾向于增加其与血管紧张素转换酶II(病毒在宿主细胞上的受体)复合概率的一系列构象变化。此外,还会考虑血管紧张素转换酶II的催化胞外域以其可溶形式在细胞外空间的释放及其对病毒感染性的正面或负面影响。